• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GW Pharmaceuticals PLC

+ Add to Watchlist

GWPRF:US

7.1500 USD 0.1060 1.46%

As of 20:10:00 ET on 09/19/2014.

Snapshot for GW Pharmaceuticals PLC (GWPRF)

Open: 7.2400 Day's Range: 7.1500 - 7.2700 Volume: 43,225
Previous Close: 7.2560 52wk Range: 1.2000 - 9.3500 1-Yr Rtn: +472.00%

Stock Chart for GWPRF

No chart data available.
  • GWPRF:US 7.1500
  • 1D
  • 1M
  • 1Y
7.2560
Interactive GWPRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GWPRF

Current P/E Ratio (ttm) -
Estimated P/E(09/2014) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (09/2014) -0.0870
Est. PEG Ratio -
Market Cap (M USD) 1,690.28
Shares Outstanding (M) 236.40
30 Day Average Volume 18,278
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GWPRF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for GWPRF

GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.

Geoffrey William GuyChairman/FounderJustin David GoverChief Executive Officer
Adam David GeorgeCFO/SecretaryChristopher John Tovey "Chris"Chief Operating Officer
More Company Profile & Key Executives for GWPRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil